The Company's plans also include studying tecarfarin in patients with mechanical heart valves experiencing anticoagulation ... now available for the Tech Tackles Cancer (TTC) Boston 10th anniversary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback